Cancer therapy using CLDN6 target-directed antibodies in vivo
US-9718886-B2 · Aug 1, 2017 · US
This page is not indexed by search engines while we improve data quality.
Tureci Ozlem patents
Tureci Ozlem holds 7 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 7 |
| Recent patents | 0 |
| First publication | Feb 3, 2015 |
| Latest publication | Aug 1, 2017 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Antibodies specific for claudin 6 (CLDN6)
US-9487584-B2 · Nov 8, 2016 · US
Antibodies for treatment of cancer
US-9321842-B2 · Apr 26, 2016 · US
Monoclonal antibodies for treatment of cancer
US-9216218-B2 · Dec 22, 2015 · US
Monoclonal antibodies against claudin-18 for treatment of cancer
US-9212228-B2 · Dec 15, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Cancer therapy using CLDN6 target-directed antibodies in vivo
US-9718886-B2 · Aug 1, 2017 · US
Antibodies specific for claudin 6 (CLDN6)
US-9487584-B2 · Nov 8, 2016 · US
Antibodies for treatment of cancer
US-9321842-B2 · Apr 26, 2016 · US
Monoclonal antibodies for treatment of cancer
US-9216218-B2 · Dec 22, 2015 · US
Monoclonal antibodies against claudin-18 for treatment of cancer
US-9212228-B2 · Dec 15, 2015 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 7 |
| Human Necessities | 6 |